TY - CHAP AU - Prins, M. AU - and Otten, H. M. M. ED - Lugassy, G. ED - Falanga, A. ED - Kakkar, A. ED - Rickles, F. PY - 2004 DA - 2004// TI - Thrombosis and cancer: A short history of Trousseau's syndrome BT - Thrombosis and Cancer PB - Taylor and Francis London CY - New York UR - https://doi.org/10.3109/9780203502181-2 DO - 10.3109/9780203502181-2 ID - Prins2004 ER - TY - JOUR AU - Walz, D. A. AU - and Fenton, J. W. PY - 1994 DA - 1994// TI - The role of thrombin in tumor cell metastasis JO - Invasion Metastasis VL - 14 ID - Walz1994 ER - TY - JOUR AU - Nierodzik, M. L. AU - and Karpatkin, S. PY - 2006 DA - 2006// TI - Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype JO - Cancer Cell VL - 10 UR - https://doi.org/10.1016/j.ccr.2006.10.002 DO - 10.1016/j.ccr.2006.10.002 ID - Nierodzik2006 ER - TY - JOUR AU - Coughlin, S. R. PY - 2005 DA - 2005// TI - Protease-activated receptors in hemostasis, thrombosis and vascular biology JO - J Thromb Haemost VL - 3 UR - https://doi.org/10.1111/j.1538-7836.2005.01377.x DO - 10.1111/j.1538-7836.2005.01377.x ID - Coughlin2005 ER - TY - JOUR AU - Hollenberg, M. D. AU - Compton, S. J. PY - 2002 DA - 2002// TI - International Union of Pharmacology. XXVIII. Proteinase-activated receptors JO - Pharmacol Rev VL - 54 UR - https://doi.org/10.1124/pr.54.2.203 DO - 10.1124/pr.54.2.203 ID - Hollenberg2002 ER - TY - JOUR AU - Ossovskaya, V. S. AU - Bunnett, N. W. PY - 2004 DA - 2004// TI - Protease-activated receptors: contribution to physiology and disease JO - Physiol Rev VL - 84 UR - https://doi.org/10.1152/physrev.00028.2003 DO - 10.1152/physrev.00028.2003 ID - Ossovskaya2004 ER - TY - JOUR AU - Steinhoff, M. AU - Buddenkotte, J. AU - Hollenberg, M. D. PY - 2005 DA - 2005// TI - Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response JO - Endocr Rev VL - 26 UR - https://doi.org/10.1210/er.2003-0025 DO - 10.1210/er.2003-0025 ID - Steinhoff2005 ER - TY - JOUR AU - Ramachandran, R. AU - Hollenberg, M. D. PY - 2008 DA - 2008// TI - Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more JO - Br J Pharmacol VL - 153 ID - Ramachandran2008 ER - TY - JOUR AU - Nystedt, S. AU - Emilsson, K. AU - Wahlestedt, C. AU - Sundelin, J. PY - 1994 DA - 1994// TI - Molecular cloning a potential proteinase activated receptor JO - Proc Natl Acad Sci USA VL - 91 UR - https://doi.org/10.1073/pnas.91.20.9208 DO - 10.1073/pnas.91.20.9208 ID - Nystedt1994 ER - TY - JOUR AU - Even-Ram, S. AU - Uziely, B. AU - Bar-Shavit, R. PY - 1998 DA - 1998// TI - Thrombin receptor overexpression in malignant and physiological invasion processes JO - Nat Med VL - 4 UR - https://doi.org/10.1038/nm0898-909 DO - 10.1038/nm0898-909 ID - Even-Ram1998 ER - TY - JOUR AU - Even-Ram, S. C. AU - Maoz, M. AU - Bar-Shavit, R. PY - 2001 DA - 2001// TI - Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M007027200 DO - 10.1074/jbc.M007027200 ID - Even-Ram2001 ER - TY - JOUR AU - Lafleur, M. A. AU - Hollenberg, M. D. AU - Atkinson, S. J. AU - Knäuper, V. AU - Murphy, G. AU - Edwards, D. R. PY - 2001 DA - 2001// TI - Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species JO - Biochem J VL - 357 UR - https://doi.org/10.1042/bj3570107 DO - 10.1042/bj3570107 ID - Lafleur2001 ER - TY - JOUR AU - Seiki, M. PY - 2003 DA - 2003// TI - Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion JO - Cancer Lett VL - 194 UR - https://doi.org/10.1016/S0304-3835(02)00699-7 DO - 10.1016/S0304-3835(02)00699-7 ID - Seiki2003 ER - TY - JOUR AU - Bissell, M. J. AU - Radisky, D. PY - 2001 DA - 2001// TI - Putting tumors in context JO - Nat Rev Cancer VL - 1 UR - https://doi.org/10.1038/35094059 DO - 10.1038/35094059 ID - Bissell2001 ER - TY - JOUR AU - Egeblad, M. AU - Werb, Z. PY - 2002 DA - 2002// TI - New functions for the matrix metalloproteinases in cancer progression JO - Nat Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc745 DO - 10.1038/nrc745 ID - Egeblad2002 ER - TY - JOUR AU - López-Otín, C. AU - Matrisian, L. M. PY - 2007 DA - 2007// TI - Emerging roles of proteases in tumour suppression JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2228 DO - 10.1038/nrc2228 ID - López-Otín2007 ER - TY - JOUR AU - Matsuoka, T. AU - Yashiro, M. AU - Sawada, T. AU - Ishikawa, T. AU - Ohira, M. AU - Hirakawa, K. AU - Chung, Y. S. PY - 2001 DA - 2001// TI - Effect of a matrix metalloproteinase inhibitor on a lymph node metastatic model of gastric cancer cells passage by orthotopic implantation JO - J Exp Clin Cancer Res VL - 20 ID - Matsuoka2001 ER - TY - JOUR AU - Boire, A. AU - Covic, L. AU - Agarwal, A. AU - Jacques, S. AU - Sherifi, S. AU - Kulipulos, A. PY - 2005 DA - 2005// TI - PAR1 is a matrix metalloproteinase-1 receptor that promotes invasion and tumorigenesis of breast cancer cells JO - Cell VL - 120 UR - https://doi.org/10.1016/j.cell.2004.12.018 DO - 10.1016/j.cell.2004.12.018 ID - Boire2005 ER - TY - JOUR AU - Darmoul, D. AU - Gratio, V. AU - Devaud, H. AU - Peiretti, F. AU - Laburthe, M. PY - 2004 DA - 2004// TI - Activation of Proteinase-Activated Receptor 1 promotes human colon cancer proliferation through Epidermal Growth Factor Receptor transactivation JO - Mol Cancer Res VL - 2 ID - Darmoul2004 ER - TY - JOUR AU - Bergmann, S. AU - Junker, K. AU - Henklein, P. AU - Hollenberg, M. D. AU - Settmacher, U. AU - Kaufmann, R. PY - 2006 DA - 2006// TI - PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration JO - Oncol Rep VL - 15 ID - Bergmann2006 ER - TY - JOUR AU - Tantivejkul, K. AU - Lodberg, D. R. AU - Pienta, J. K. PY - 2005 DA - 2005// TI - PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism JO - J Cell Biochem VL - 96 UR - https://doi.org/10.1002/jcb.20533 DO - 10.1002/jcb.20533 ID - Tantivejkul2005 ER - TY - JOUR AU - Fujimoto, D. AU - Hirono, Y. AU - Goi, T. AU - Katayama, K. AU - Yamaguchi, A. PY - 2008 DA - 2008// TI - Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer JO - Anticancer Res VL - 28 ID - Fujimoto2008 ER - TY - JOUR AU - De Wever, O. AU - Nguyen, Q. D. AU - Van Hoorde, L. AU - Bracke, M. AU - Bruyneel, E. AU - Gespach, C. AU - Mareel, M. PY - 2004 DA - 2004// TI - Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac JO - FASEB J VL - 18 ID - De Wever2004 ER - TY - JOUR AU - Ahn, H. S. AU - Foster, C. AU - Boykow, G. AU - Stamford, A. AU - Manna, M. AU - Granziano, M. PY - 2000 DA - 2000// TI - Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methlethyl-)phenyl]methyl}-7H-pyrrolo[3,2-f] quinazoline-1,3-diamine (SCH79797), a nonpeptide thrombin receptor antagonist JO - Biochem Pharmacol VL - 60 UR - https://doi.org/10.1016/S0006-2952(00)00460-3 DO - 10.1016/S0006-2952(00)00460-3 ID - Ahn2000 ER - TY - JOUR AU - Natarajan, K. AU - Singh, S. AU - Bruke, T. R. AU - Grunberger, D. AU - Aggarwal, B. B. PY - 1996 DA - 1996// TI - Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B JO - Proc Natl Acad Sci USA VL - 93 UR - https://doi.org/10.1073/pnas.93.17.9090 DO - 10.1073/pnas.93.17.9090 ID - Natarajan1996 ER - TY - JOUR AU - Mann, K. G. AU - Brummel, K. AU - Butenas, S. PY - 2003 DA - 2003// TI - What is all that thrombin for? JO - J Thromb Haemost VL - 1 UR - https://doi.org/10.1046/j.1538-7836.2003.00298.x DO - 10.1046/j.1538-7836.2003.00298.x ID - Mann2003 ER - TY - JOUR AU - Kawabata, A. AU - Saifeddine, M. AU - Al-Ani, B. AU - Leblond, L. AU - Hollenberg, M. D. PY - 1999 DA - 1999// TI - Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands JO - J Pharmacol Exp Ther VL - 288 ID - Kawabata1999 ER - TY - JOUR AU - Albini, A. AU - Iwamoto, Y. AU - Kleinman, H. K. AU - Martin, G. R. AU - Aaroonson, S. A. AU - Kozlowski, J. M. AU - McEwan, R. N. PY - 1987 DA - 1987// TI - A rapid in vitro assay for quantitating the invasive potential of tumor cells JO - Cancer Res VL - 47 ID - Albini1987 ER - TY - JOUR AU - Kuliopulos, A. AU - Covic, L. AU - Seeley, S. K. AU - Sheridan, P. J. AU - Helin, J. AU - Costello, C. E. PY - 1999 DA - 1999// TI - Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy JO - Biochemistry VL - 38 UR - https://doi.org/10.1021/bi9824792 DO - 10.1021/bi9824792 ID - Kuliopulos1999 ER - TY - JOUR AU - Ishii, K. AU - Hein, L. AU - Kobilka, B. AU - Coughlin, S. R. PY - 1993 DA - 1993// TI - Kinetics of thrombin receptor cleavage on intact cells-relation to signaling JO - J Biol Chem VL - 268 ID - Ishii1993 ER - TY - JOUR AU - Vouret-Craviari, V. AU - Van Obberghen-Schilling, E. AU - Scimeca, J. C. AU - Van Obberghen, E. AU - Pouysségur, J. PY - 1993 DA - 1993// TI - Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist JO - Biochem J VL - 289 UR - https://doi.org/10.1042/bj2890209 DO - 10.1042/bj2890209 ID - Vouret-Craviari1993 ER - TY - JOUR AU - Hollenberg, M. D. AU - Mokashi, M. AU - Leblond, L. AU - DiMaio, J. PY - 1996 DA - 1996// TI - Synergistic actions of a thrombin-derived synthetic peptide and a thrombin receptor-activating peptide in stimulating fibroblasts mitogenesis JO - J Cell Physiol VL - 169 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - Hollenberg1996 ER - TY - JOUR AU - Mari, B. AU - Imbert, V. AU - Auberger, P. PY - 1994 DA - 1994// TI - Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production JO - J Biol Chem VL - 269 ID - Mari1994 ER - TY - JOUR AU - Swindle, C. S. AU - Tran, K. T. AU - Johnson, T. D. AU - Banerjee, P. AU - Mayes, A. M. AU - Griffith, L. AU - Wells, A. PY - 2001 DA - 2001// TI - Epidermal growth factor (EGF)-like repeats of human Tenascin-C a ligands for EGF receptor JO - J Cell Biol VL - 154 UR - https://doi.org/10.1083/jcb.200103103 DO - 10.1083/jcb.200103103 ID - Swindle2001 ER - TY - JOUR AU - Ohno, Y. AU - Izumi, M. AU - Yoshioka, K. AU - Ohori, M. AU - Yonou, H. AU - Tachibana, M. PY - 2008 DA - 2008// TI - Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma JO - Oncol Rep VL - 20 ID - Ohno2008 ER - TY - JOUR AU - Maschler, S. AU - Grunert, S. AU - Danielopol, A. AU - Beug, H. AU - Wirl, G. PY - 2004 DA - 2004// TI - Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207403 DO - 10.1038/sj.onc.1207403 ID - Maschler2004 ER - TY - JOUR AU - Emoto, K. AU - Yamada, Y. AU - Nakajima, Y. PY - 2001 DA - 2001// TI - Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma JO - Cancer VL - 92 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - Emoto2001 ER - TY - JOUR AU - Orend, G. AU - Chiquet-Ehrismann, R. PY - 2006 DA - 2006// TI - Teanscin-C induced signaling in cancer JO - Cancer Lett VL - 244 UR - https://doi.org/10.1016/j.canlet.2006.02.017 DO - 10.1016/j.canlet.2006.02.017 ID - Orend2006 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/10/443/prepub UR - http://www.biomedcentral.com/1471-2407/10/443/prepub ID - ref39 ER -